Deleted in Liver Cancer 2 (DLC2) Was Dispensable for Development and Its Deficiency Did Not Aggravate Hepatocarcinogenesis

Tai On Yau, Thomas Ho Yin Leung, Sandra Lam et al. · 2009

Read Deleted in Liver Cancer 2 (DLC2) Was Dispensable for Development and Its Deficiency Did Not Aggravate Hepatocarcinogenesis by Tai On Yau, Thomas Ho Yin Leung, Sandra Lam et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0006566.txt.

Description

Tai On Yau and co-authors tested whether a liver cancer gene is essential in PLOS ONE in 2009. DLC2, deleted in liver cancer 2, is a Rho GTPase-activating protein. It was previously shown to be underexpressed in human hepatocellular carcinoma and to have tumor suppressor functions. The team deleted it in mice to test its importance.

Their title reports DLC2 was dispensable for development. Its deficiency did not aggravate hepatocarcinogenesis, liver cancer formation, either. A protein can be lost in tumors yet not drive them. That distinction saves research from chasing bystanders. It also highlights backup systems in development.

Catalog record

CREATORTai On Yau, Thomas Ho Yin Leung, Sandra Lam et al.
YEAR2009
COLLECTIONPAPERS
FORMATTXT
FILE SIZE32 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0006566

Browse the full library · About the Tower of Babel